Example: Heart Attack

Search clinical trials for: Paclitaxel

Total 3794 results

NCT04568200

Recruiting

Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Resectable Esophageal Squamous Cell Carcinoma

Conditions: Esophageal Squamous Cell Carcinoma
NCT04564157

Not yet recruiting

NADIM-ADJUVANT: New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy

Conditions: Non-Small Cell Lung Cancer; Adjuvant Chemotherapy
NCT04564482

Not yet recruiting

PD-L1 PET Imaging During Neoadjuvant (Chemo)Radiotherapy in Esophageal and Rectal Cancer

Conditions: Rectal Cancer Stage; Oesophageal Cancer
NCT04561739

Not yet recruiting

Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery Lesions

Conditions: De Novo Stenosis; Coronary Artery Disease
NCT04561817

Not yet recruiting

To Evaluate the Safety and Efficacy of Ipatasertib (GDC-0068) in Combination With Paclitaxel in Platinum-resistant Recurrent Epithelial Ovarian Cancer

Conditions: Ovarian Neoplasms
NCT04558034

Recruiting

The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer

Conditions: Cryotherapy Effect; Peripheral Neuropathy; Nail Toxicity
NCT04559308

Recruiting

The Effect of Metformin on Breast Cancer Patients

Conditions: Breast Cancer
NCT04556773

Not yet recruiting

A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer

Conditions: Metastatic Breast Cancer
NCT04554524

Recruiting

Chemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma

Conditions: Thymoma
NCT04554771

Not yet recruiting

Blood-borne Assessment of Stromal Activation in Esophageal Adenocarcinoma to Guide Tocilizumab Therapy

Conditions: Esophageal Adenocarcinoma; Oesophageal Adenocarcinoma; Resectable Carcinoma
NCT04555226

Recruiting

The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103)

Conditions: Cervical Cancer
NCT04555304

Not yet recruiting

Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapy

Conditions: Gastric Cancer; Gastroesophageal Cancer
NCT04551950

Not yet recruiting

Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer

Conditions: Cervical Cancer
NCT04546828

Not yet recruiting

A Single-arm Study of Gemcitabine, Cisplatin, and Nab-Paclitaxel as Neoadjuvant Therapy for Resectable Oncologically High-Risk IHCC in Korea

Conditions: Intrahepatic Cholangiocarcinoma
NCT04547504

Not yet recruiting

PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %

Conditions: Non-small-cell Lung Cancer
NCT04547907

Recruiting

Comparing the Efficacy of Nab-PHP and TCbHP in Neoadjuvant Therapy for HER2 Positive Operable Breast Cancer, A Multicenter, Randomized, Phase III Clinical Trial

Conditions: Breast Cancer,Her2 Positive
NCT04548440

Recruiting

Efficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC Patients

Conditions: Esophageal Squamous Cell Carcinoma
NCT04543175

Completed

Taste Disorders and Their Relation to BMI, FFQ, and EORTC QLQ-BR23 in Breast Cancer Patients During Chemotherapy.

Conditions: Breast Cancer; Taste Disorders; Dysgeusia; Ageusia; Quality of Life
NCT04541108

Not yet recruiting

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

Conditions: Solid Tumor
NCT04541251

Not yet recruiting

Neoadjuvant Camrelizumab, Nab-paclitaxel and Carboplatin in Stage IB-IIIA NSCLC

Conditions: Lung Cancer, Non-small Cell
NCT04543071

Not yet recruiting

Chemo4METPANC Combination Chemotherapy in Patients With Pancreatic Adenocarcinoma

Conditions: Pancreatic Cancer; Adenocarcinoma of the Pancreas; Adenocarcinoma
NCT04539808

Not yet recruiting

NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable or Borderline Resectable Pancreatic Cancer

Conditions: Borderline Resectable Pancreatic Carcinoma; Resectable Pancreatic Ductal Adenocarcinoma; Stage 0 Pancreatic Cancer AJCC v8; Stage I Pancreatic Cancer AJCC v8; Stage IA Pancreatic Cancer AJCC v8; Stage IB Pancreatic Cancer AJCC v8
NCT04540211

Recruiting

A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma

Conditions: Esophageal Cancer
NCT04540692

Not yet recruiting

Evaluation of Sequencing of Anthracyclines and Taxanes for Locally Advanced HER2-negative Breast Cancer

Conditions: Breast Cancer
NCT04538742

Not yet recruiting

A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer

Conditions: Metastatic Breast Cancer
NCT04538833

Recruiting

Monosialic Gangliosides to Treat Paclitaxel / Docetaxel Neurotoxicity

Conditions: Early Breast Cancer
NCT04537286

Recruiting

First-line Nab-paclitaxel Plus Cisplatin Plus Carilizumab in mTNBC Patients

Conditions: Breast Cancer
NCT04530227

Not yet recruiting

Camrelizumab With Chemotherapy in Adults With Medically Inoperable Early Stage NSCLC

Conditions: Early Stage Non-small Cell Lung Cancer
NCT04527900

Not yet recruiting

The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach

Conditions: Endometrial Cancer
NCT04527991

Not yet recruiting

Study of Sacituzumab Govitecan (IMMU-132) in Metastatic or Locally Advanced Unresectable Urothelial Cancer

Conditions: Urothelial Carcinoma; Bladder Cancer; Metastatic Urothelial Carcinoma; Locally Advanced Urothelial Cancer; Transitional Cell Carcinoma
NCT04528680

Not yet recruiting

Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel for Recurrent Glioblastoma

Conditions: Glioblastoma; Gliosarcoma; GBM; Glioblastoma Multiforme; Glioblastoma, IDH-wildtype; Recurrent Glioblastoma
NCT04526470

Not yet recruiting

Alpelisib and Paclitaxel in PIK3CA-altered Gastric Cancer

Conditions: Solid Tumor; Stomach Cancer
NCT04523987

Recruiting

A Pilot Study of Ciprofloxacin Plus Gemcitabine and Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.

Conditions: Metastatic Pancreatic Ductal Adenocarcinoma
NCT04524299

Recruiting

Study of Radiotherapy Combined With Albumin Bound Paclitaxel and Nedaplatin for Locally Advanced NSCLC

Conditions: Non-small Cell Lung Cancer
NCT04524702

Recruiting

Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced or Metastatic Pancreatic Cancer

Conditions: Advanced Pancreatic Adenocarcinoma; Metastatic Pancreatic Adenocarcinoma; Stage IV Pancreatic Cancer AJCC v8
NCT04519905

Recruiting

Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)

Conditions: Esophageal Squamous Cell Carcinoma; Chemoradiotherapy; Survival
NCT04520035

Recruiting

Neoadjuvant Chemotherapy With Camrelizumab in Locally Advanced Esophageal Squamous Cell

Conditions: PFS
NCT04518800

Not yet recruiting

PEG-rhG-CSF in Secondary Prevention of Nab-Paclitaxel Combined With S-1 in Advanced Pancreatic Cancer

Conditions: PEG-rhG-CSF; Pancreatic Cancer
NCT04516616

Not yet recruiting

Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer

Conditions: Uterine Cervical Neoplasm; Uterine Cervical Cancer; Cervical Cancer
NCT04515602

Not yet recruiting

Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS)

Conditions: Epithelial Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinoma
NCT04506138

Recruiting

Camrelizumab in Combination With Neoadjuvant Chemotherapy for Resectable Thoracic Esophageal Squamous Cell Carcinoma

Conditions: Esophageal Squamous Cell Carcinoma
NCT04503668

Not yet recruiting

Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients

Conditions: Gynecologic Cancer
NCT04502641

Recruiting

Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial

Conditions: Hypopharyngeal Cancer
NCT04499118

Not yet recruiting

AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer

Conditions: HER2-negative Breast Cancer
NCT04499924

Not yet recruiting

Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer

Conditions: Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma; Esophageal Adenocarcinoma
NCT04498117

Recruiting

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Conditions: Carcinoma, Ovarian Epithelial; Ovarian Neoplasms; Ovarian Cancer; Ovarian Serous Adenocarcinoma; Fallopian Tube Neoplasms; Fallopian Tube Adenocarcinoma; Fallopian Tube Serous Adenocarcinoma; Peritoneal Cancer; Peritoneal Carcinoma; Peritoneal Neoplasms
NCT04498689

Recruiting

Efficacy and Safety of Camrelizumab Combined With Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer

Conditions: Metastatic Pancreatic Cancer
NCT04498793

Not yet recruiting

Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer

Conditions: HER2-negative Breast Cancer
NCT04496544

Active, not recruiting

Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD Study)

Conditions: Peripheral Arterial Disease; Paclitaxel Adverse Reaction; Safety Issues
NCT04494425

Recruiting

Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer

Conditions: Advanced or Metastatic Breast Cancer

COOKIE SETTINGS

Search clinical trials for: Paclitaxel